B. Xiong

发表

ScafBank: a public comprehensive Scaffold database to support molecular hopping

Bing Xiong, Ke Liu, B. Yan, 2009, Acta Pharmacologica Sinica.

Fragment-based drug discovery of 2-thiazolidinones as inhibitors of the histone reader BRD4 bromodomain.

Yechun Xu, Lele Zhao, Z. Miao, 2013, Journal of medicinal chemistry.

CCLab--a multi-objective genetic algorithm based combinatorial library design software and an application for histone deacetylase inhibitor design.

Mengzhu Xue, B. Xiong, Jing-kang Shen, 2012, Bioorganic & medicinal chemistry letters.

Brownian dynamics simulations of the recognition of the scorpion toxin maurotoxin with the voltage-gated potassium ion channels.

Xiaomin Luo, Kaixian Chen, Hualiang Jiang, 2002, Biophysical journal.

Design, synthesis and antitumor evaluation of a new series of N-substituted-thiourea derivatives

Jian Li, Hong Liu, Bing Xiong, 2006, Acta Pharmacologica Sinica.

Mechanism of the All-α to All-β Conformational Transition of RfaH-CTD: Molecular Dynamics Simulation and Markov State Model.

Xiaomin Luo, Kaixian Chen, Hualiang Jiang, 2014, Journal of chemical theory and computation.

Design and Synthesis of 4‐(2,4,5‐Trifluorophenyl)butane‐1,3‐diamines as Dipeptidyl Peptidase IV Inhibitors

B. Xiong, Jing-kang Shen, Xin Wang, 2013, ChemMedChem.

Fragment-Based Drug Discovery for Developing Inhibitors of Protein-Protein Interactions

B. Xiong, Jing-kang Shen, Qi Wang, 2018 .

Inhibitory mode of 1,5-diarylpyrazole derivatives against cyclooxygenase-2 and cyclooxygenase-1: molecular docking and 3D QSAR analyses.

Bing Xiong, Kaixian Chen, Jianhua Shen, 2002, Journal of medicinal chemistry.

Divalent tranylcypromine derivative as lysine-specific demethylase 1 inhibitor

Tongchao Liu, Yu-bo Zhou, B. Xiong, 2021, Medicinal Chemistry Research.

Studies on anti-tumour activities of pseudolaric acid-B (PLAB) and its mechanism of action

B. Xiong, B. Liu, H. Chen, 2006, Journal of Asian natural products research.

Design and synthesis of benzylpiperidine inhibitors targeting the menin-MLL1 interface.

Yu-bo Zhou, Yi Zang, W. Xu, 2016, Bioorganic & medicinal chemistry letters.

Discovery of MTR-106 as a highly potent G-quadruplex stabilizer for treating BRCA-deficient cancers

Z. Miao, B. Xiong, Jing-kang Shen, 2021, Investigational New Drugs.

Potent and novel 11β-HSD1 inhibitors identified from shape and docking based virtual screening.

Bing Xiong, Jingkang Shen, Guangxin Xia, 2011, Bioorganic & medicinal chemistry letters.

Design and Synthesis of (R)‐1‐Arylsulfonylpiperidine‐2‐carboxamides as 11β‐Hydroxysteroid Dehydrogenase Type 1 Inhibitors

B. Xiong, Jing-kang Shen, Haiyan Liu, 2013, ChemMedChem.

Discovery of 2-Alkyl-1-arylsulfonylprolinamides as 11β-Hydroxysteroid Dehydrogenase Type 1 Inhibitors.

B. Xiong, Jing-kang Shen, Jianxin Yu, 2012, ACS medicinal chemistry letters.

Dopamine D 1 Receptor Ligands: Where AreWe Now and Where AreWe Going

Xuechu Zhen, A. Zhang, B. Xiong, 2009 .

FS-93, an Hsp90 inhibitor, induces G2/M arrest and apoptosis via the degradation of client proteins in oncogene addicted and derived resistant cancer cells

M. Geng, B. Xiong, Jing-kang Shen, 2015, Oncoscience.

FS-93 , an Hsp 90 inhibitor , induces G 2 / M arrest and apoptosis via the degradation of client proteins in oncogene addicted and derived resistant cancer cells

M. Geng, B. Xiong, Jing-kang Shen, 2015 .

MiR-182-5p inhibited proliferation and metastasis of colorectal cancer by targeting MTDH.

B. Xiong, Y. Huang, Z-L Zhang, 2019, European review for medical and pharmacological sciences.

Multi-substituted 8-aminoimidazo[1,2-a]pyrazines by Groebke-Blackburn-Bienaymé reaction and their Hsp90 inhibitory activity.

J. Li, Min Yang, M. Geng, 2015, Organic & biomolecular chemistry.

Discovery of potent N-(isoxazol-5-yl)amides as HSP90 inhibitors.

Yechun Xu, Min Huang, M. Geng, 2014, European journal of medicinal chemistry.

FS23 binds to the N-terminal domain of human Hsp90:A novel small inhibitor for Hsp90

Ji-Hao Li, B. Xiong, Jianhua He, 2015 .

The Novel RET Inhibitor SYHA1815 Inhibits RET-Driven Cancers and Overcomes Gatekeeper Mutations by Inducing G1 Cell-Cycle Arrest through c-Myc Downregulation

Yi Chen, Youhong Hu, Yan-fen Fang, 2021, Molecular Cancer Therapeutics.

Structure-based Discovery of a Series of NSD2-PWWP1 Inhibitor

M. Geng, Jian Li, B. Xiong, 2021 .

Design, synthesis and SAR of piperidyl-oxadiazoles as 11β-hydroxysteroid dehydrogenase 1 inhibitors.

B. Xiong, Jing-kang Shen, Haiyan Liu, 2013, European journal of medicinal chemistry.

Condensed Fukui function predicts innate C–H radical functionalization sites on multi-nitrogen containing fused arenes

B. Xiong, Jing-kang Shen, Dongmei Zhao, 2014 .

Formation of 1,3-diazocine by palladium catalyzed C–H arylation

B. Xiong, Jing-kang Shen, Jingge Ren, 2016 .

Sulfated polymannuroguluronate inhibits Tat-induced SLK cell adhesion via a novel binding site, a KKR spatial triad

M. Geng, Yan-lin Wu, B. Xiong, 2011, Acta Pharmacologica Sinica.

EPHA2 feedback activation limits the response to PDEδ inhibition in KRAS-dependent cancer cells

Min Huang, Jian Ding, M. Geng, 2019, Acta Pharmacologica Sinica.

Dopamine D1 receptor ligands: Where are we now and where are we going

Xuechu Zhen, A. Zhang, B. Xiong, 2009, Medicinal research reviews.

A new BET inhibitor, 171, inhibits tumor growth through cell proliferation inhibition more than apoptosis induction

Z. Miao, B. Xiong, Jing-kang Shen, 2019, Investigational New Drugs.

Fragment-based drug discovery of triazole inhibitors to block PDEδ-RAS protein-protein interaction.

M. Huang, Min Huang, M. Geng, 2019, European journal of medicinal chemistry.

Crystallization and preliminary crystallographic analysis of an aminoglycoside kinase from Legionella pneumophila.

A. Berghuis, N. Cianciotto, B. Xiong, 2005, Acta crystallographica. Section F, Structural biology and crystallization communications.

Identification of 1H-pyrazolo[3,4-b]pyridine derivatives as novel and potent TBK1 inhibitors: design, synthesis, biological evaluation, and molecular docking study

Tongchao Liu, B. Xiong, Hua Xie, 2022, Journal of enzyme inhibition and medicinal chemistry.

Phage-Display Based Discovery and Characterization of Peptide Ligands against WDR5

B. Xiong, Jing-kang Shen, D. Cao, 2021, Molecules.

Quinoxalinylurea Derivatives as a Novel Class of JSP‐1 Inhibitors.

B. Xiong, Jing-kang Shen, Xin Wang, 2007 .

Molecular Determinants for the High-Affinity Blockade of Human Ether-à-go-go-Related Gene K+ Channel by Tolterodine

B. Xiong, Jian Li, Jin Zhang, 2022, Journal of cardiovascular pharmacology.

In situ constructed oxygen-vacancy-rich MoO3−x/porous g-C3N4 heterojunction for synergistically enhanced photocatalytic H2 evolution

Yan Wu, B. Xiong, Yufeng Pan, 2021, RSC advances.

Structure-Based Discovery of Potent CARM1 Inhibitors for Solid Tumor and Cancer Immunology Therapy.

Zhuqing Zhang, M. Geng, B. Xiong, 2021, Journal of medicinal chemistry.

Convenient preparation of pinometostat and related 5′-deoxy-5′-amino adenosine derivatives as well as their activity against DOT1L

Tongchao Liu, Jia Li, Yu-bo Zhou, 2018 .

Preparation of 5'-deoxy-5'-amino-5'-C-methyl adenosine derivatives and their activity against DOT1L.

Tongchao Liu, Yu-bo Zhou, B. Xiong, 2017, Bioorganic & medicinal chemistry letters.

Inhibition of the BET family reduces its new target gene IDO1 expression and the production of l-kynurenine

Z. Miao, B. Xiong, Jing-kang Shen, 2019, Cell Death & Disease.

Discovery of Novel N-(5-(Pyridin-3-yl)-1H-indazol-3-yl)benzamide Derivatives as Potent Cyclin-Dependent Kinase 7 Inhibitors for the Treatment of Autosomal Dominant Polycystic Kidney Disease.

Tongchao Liu, Yu-bo Zhou, B. Xiong, 2022, Journal of medicinal chemistry.

Structure-activity relationship study of a series of nucleoside derivatives bearing sulfonamide scaffold as potent and selective PRMT5 inhibitors.

Jia Liu, Tongchao Liu, B. Xiong, 2022, Bioorganic chemistry.

Efficient syntheses of alpha- and beta-C-nucleosides and the origin of anomeric selectivity

Tongchao Liu, B. Xiong, Jing-kang Shen, 2018 .

Quinoxalinylurea derivatives as a novel class of JSP-1 inhibitors.

B. Xiong, Jing-kang Shen, Xin Wang, 2007, Bioorganic & medicinal chemistry letters.

Highly Stereoselective Nucleophilic Addition of Difluoromethyl‐2‐pyridyl Sulfone to Sugar Lactones and Efficient Synthesis of Fluorinated 2‐Ketoses

B. Xiong, Jing-kang Shen, Jian Yin, 2014 .

Multi-omics characterization of WNT pathway reactivation to ameliorate BET inhibitor resistance in liver cancer cells.

Xin Hu, Jingkang Shen, Z. Miao, 2021, Genomics.

Discovery of a series of dihydroquinoxalin-2(1H)-ones as selective BET inhibitors from a dual PLK1-BRD4 inhibitor.

Z. Miao, B. Xiong, Jing-kang Shen, 2017, European journal of medicinal chemistry.

Direct glycosylation of bioactive small molecules with glycosyl iodide and strained olefin as acid scavenger.

B. Xiong, Jing-kang Shen, Xin Wang, 2014, The Journal of organic chemistry.

Strained olefin enables triflic anhydride mediated direct dehydrative glycosylation.

B. Xiong, Jing-kang Shen, Jian Yin, 2014, Organic & biomolecular chemistry.

Discovery of pyrazole as C-terminus of selective BACE1 inhibitors.

Yechun Xu, Li Li, Jian Li, 2013, European journal of medicinal chemistry.

Illudalic acid as a potential LAR inhibitor: synthesis, SAR, and preliminary studies on the mechanism of action.

B. Xiong, Jing-kang Shen, Xin Wang, 2008, Bioorganic & medicinal chemistry.

Structural Analysis of a Novel Cyclohexylamine Oxidase from Brevibacterium oxydans IH-35A

A. Berghuis, D. Burk, B. Xiong, 2013, PloS one.

Design and optimization of a series of 1-sulfonylpyrazolo[4,3-b]pyridines as selective c-Met inhibitors.

Jian Ding, M. Geng, B. Xiong, 2015, Journal of medicinal chemistry.

Stereoselective addition of Grignard reagents to (2-methyl-5-tert-butyl)phenyl 1-thio-β-D-ribopentodialdo-1,4-furanoside derivative

B. Xiong, Jing-kang Shen, Guohua Chen, 2017 .

Novel bivalent BET inhibitor N2817 exhibits potent anticancer activity and inhibits TAF1.

Z. Miao, B. Xiong, Qian Wu, 2021, Biochemical pharmacology.

2-Pyrones from endophytic fungus Diaporthe foeniculina BZM-15

Jaehyuck Choi, Sasa Wang, B. Xiong, 2021, Natural product research.

Design and Synthesis of Potent, Selective Inhibitors of Protein Arginine Methyltransferase 4 against Acute Myeloid Leukemia.

Zhuqing Zhang, Jian Ding, M. Geng, 2019, Journal of medicinal chemistry.

Stereoselective and Regioselective Preparation of C-Pentopyranosides and Formal Synthesis of Omarigliptin

Tongchao Liu, B. Xiong, Jing-kang Shen, 2016 .

Discovery of benzhydrylpiperazine derivatives as CB1 receptor inverse agonists via privileged structure-based approach.

Xin Eric Wang, B. Xiong, Jing-kang Shen, 2010, European journal of medicinal chemistry.

Stereoselective N-glycosylation with N4-acyl cytosines and efficient synthesis of gemcitabine

Tongchao Liu, B. Xiong, Jing-kang Shen, 2019, Tetrahedron.

A one-pot synthesis of omarigliptin and its analogues through stabilized beta-amino ketone intermediate

Tongchao Liu, B. Xiong, Jing-kang Shen, 2017 .

1,2-Tans-1-dihydroxyboryl benzyl S-glycoside as glycosyl donor.

B. Xiong, Jing-kang Shen, Xin Wang, 2014, Carbohydrate research.

Design, synthesis, and preliminary biological evaluation of novel ketone derivatives of shikimic acid

M. Jiang, Yu-mei Shen, B. Xiong, 2013 .

MT7, a novel compound from a combinatorial library, arrests mitosis via inhibiting the polymerization of microtubules

Jingkang Shen, Z. Miao, Jian Ding, 2010, Investigational New Drugs.

Discovery of a new series of imidazo[1,2-a]pyridine compounds as selective c-Met inhibitors

Dong-mei Zhao, M. Geng, B. Xiong, 2016, Acta Pharmacologica Sinica.

The B-RafV600E inhibitor dabrafenib selectively inhibits RIP3 and alleviates acetaminophen-induced liver injury

Z. Miao, Jian Ding, B. Xiong, 2014, Cell Death and Disease.

Targeting Hsp90 with FS-108 circumvents gefitinib resistance in EGFR mutant non-small cell lung cancer cells

Jian Ding, M. Geng, B. Xiong, 2016, Acta Pharmacologica Sinica.

Synthesis and LAR inhibition of 7-alkoxy analogues of illudalic acid.

B. Xiong, Jing-kang Shen, Xin Wang, 2010, Yao xue xue bao = Acta pharmaceutica Sinica.

Discovery of a series of dimethoxybenzene FGFR inhibitors with 5H-pyrrolo[2,3-b]pyrazine scaffold: structure–activity relationship, crystal structural characterization and in vivo study

M. Geng, B. Xiong, Jing-kang Shen, 2018, Acta pharmaceutica Sinica. B.

Discovery of novel sulfonamides as potent and selective inhibitors against human and mouse 11β-hydroxysteroid dehydrogenase type 1

Mengzhu Xue, B. Xiong, Jing-kang Shen, 2012, Molecular and Cellular Endocrinology.

Identification of methyl (5-(6-((4-(methylsulfonyl)piperazin-1-yl)methyl)-4-morpholinopyrrolo[2,1-f][1,2,4]triazin-2-yl)-4-(trifluoromethyl)pyridin-2-yl)carbamate (CYH33) as an orally bioavailable, highly potent, PI3K alpha inhibitor for the treatment of advanced solid tumors.

Yi Chen, Jian Ding, Xiaoyan Chen, 2020, European journal of medicinal chemistry.

Structure of the Antibiotic Resistance Factor Spectinomycin Phosphotransferase from Legionella pneumophila*

D. Fong, A. Berghuis, B. Xiong, 2010, The Journal of Biological Chemistry.

Author Correction: Targeting Hsp90 with FS-108 circumvents gefitinib resistance in EGFR mutant non-small cell lung cancer cells

M. Geng, B. Xiong, Jing-kang Shen, 2020, Acta Pharmacologica Sinica.

Development of a series of quinazoline-2,5-diamine derivatives as potent hematopoietic progenitor kinase 1 (HPK1) inhibitors.

Tongchao Liu, B. Xiong, Hua Xie, 2022, European journal of medicinal chemistry.

Aromatic beta-amino-ketone derivatives as novel selective non-steroidal progesterone receptor antagonists.

B. Xiong, Jing-kang Shen, Qunyi Li, 2010, Bioorganic & medicinal chemistry.

Structure-based optimization of a series of selective BET inhibitors containing aniline or indoline groups.

Z. Miao, Jian Li, B. Xiong, 2018, European journal of medicinal chemistry.

Design and discovery of new pyrimidine coupled nitrogen aromatic rings as chelating groups of JMJD3 inhibitors.

Min Huang, Jian-Ping Zuo, Rongfeng Liu, 2016, Bioorganic & medicinal chemistry letters.

Salvicine Functions as Novel Topoisomerase II Poison by Binding to ATP Pocket

Bing Xiong, Jian Ding, M. Geng, 2006, Molecular Pharmacology.

Novel PARP1/2 inhibitor mefuparib hydrochloride elicits potent in vitro and in vivo anticancer activity, characteristic of high tissue distribution

M. Wang, Yi Chen, Z. Miao, 2016, Oncotarget.

MT119, a new planar‐structured compound, targets the colchicine site of tubulin arresting mitosis and inhibiting tumor cell proliferation

Yi Chen, Z. Miao, Jian Ding, 2011, International journal of cancer.

The type IA topoisomerase catalytic cycle: A normal mode analysis and molecular dynamics simulation

Xiaomin Luo, Jianhua Shen, Hong Liu, 2008, Proteins.

Conserved α-Helix Acts as Autoinhibitory Sequence in AMP-activated Protein Kinase α Subunits*

Tao Pang, Bing Xiong, B. Xiong, 2007, Journal of Biological Chemistry.

Structure-Based Discovery of a Series of NSD2-PWWP1 Inhibitors.

Jian Li, Tongchao Liu, M. Geng, 2021, Journal of medicinal chemistry.

Structure of SARS-CoV-2 main protease in the apo state

B. Xiong, Huan Zhou, Qisheng Wang, 2020, Science China. Life sciences.

Identification of a new series of potent diphenol HSP90 inhibitors by fragment merging and structure-based optimization.

Yechun Xu, M. Geng, Jian Li, 2014, Bioorganic & medicinal chemistry letters.

Discovery of 3H‐Imidazo[4,5‐b]pyridines as Potent c‐Met Kinase Inhibitors: Design, Synthesis, and Biological Evaluation

Yi Chen, M. Geng, B. Xiong, 2012, ChemMedChem.

Preclinical Evaluation of SCC244 (Glumetinib), a Novel, Potent, and Highly Selective Inhibitor of c-Met in MET-dependent Cancer Models

Yi Chen, Jian Ding, M. Geng, 2017, Molecular Cancer Therapeutics.

Knowledge-Based Scoring Functions in Drug Design: 2. Can the Knowledge Base Be Enriched?

Jing Li, Xian Liu, Xiaomin Luo, 2011, J. Chem. Inf. Model..

Discovery of 4-cyclopropyl-3-(2-((1-cyclopropyl-1H-pyrazol-4-yl) amino) quinazolin-6-yl)-N-(3-(trifluoromethyl) phenyl) benzamides as potent discoidin domain receptor inhibitors for the treatment of idiopathic pulmonary fibrosis

Yi Zang, B. Xiong, Jia Li, 2021, Acta pharmaceutica Sinica. B.

Discovery and optimization of a series of 3-substituted indazole derivatives as multi-target kinase inhibitors for the treatment of lung squamous cell carcinoma.

M. Geng, B. Xiong, Yuchen Jiang, 2019, European journal of medicinal chemistry.

Structure-Based Discovery of a Series of 5H-Pyrrolo[2,3-b]pyrazine FGFR Kinase Inhibitors

Yechun Xu, Jian Ding, Qiu-feng Liu, 2018, Molecules.

Discovery and Biological Evaluation of a Series of Pyrrolo[2,3-b]pyrazines as Novel FGFR Inhibitors

Tongchao Liu, B. Xiong, Hongchun Liu, 2017, Molecules.

Virtual Screening and Structure-Based Discovery of Indole Acylguanidines as Potent β-secretase (BACE1) Inhibitors

Li Li, Xin Wang, Bing Xiong, 2013, Molecules.

DrugViz: a Cytoscape plugin for visualizing and analyzing small molecule drugs in biological networks

Jie Wu, Ke Liu, Hualiang Jiang, 2008, Bioinform..

Structures of aminoglycoside acetyltransferase AAC(6')-Ii in a novel crystal form: structural and normal-mode analyses.

A. Berghuis, D. Burk, C. Breitbach, 2005, Acta crystallographica. Section D, Biological crystallography.

Discovery of 1H-Imidazo[4,5-b]pyridine Derivatives as Potent and Selective BET Inhibitors for the Management of Neuropathic Pain.

Wenjing Kang, B. Xiong, D. Cao, 2023, Journal of medicinal chemistry.

Structure-based Discovery and Development of a Series of Potent and Selective Bromodomain and Extra-Terminal Protein Inhibitors.

Z. Miao, Jian Li, B. Xiong, 2019, Journal of medicinal chemistry.

Knowledge-Based Scoring Functions in Drug Design: 3. A Two-Dimensional Knowledge-Based Hydrogen-Bonding Potential for the Prediction of Protein-Ligand Interactions

Jing Li, Xian Liu, Xiaomin Luo, 2011, J. Chem. Inf. Model..

Knowledge-Based Scoring Functions in Drug Design. 1. Developing a Target-Specific Method for Kinase-Ligand Interactions

Hualiang Jiang, Mingyue Zheng, Bing Xiong, 2010, J. Chem. Inf. Model..

Structure-based discovery of potent USP28 inhibitors derived from Vismodegib.

Tongchao Liu, B. Xiong, Naixia Zhang, 2023, European journal of medicinal chemistry.

Fragment-based drug discovery of 2-thiazolidinones as BRD4 inhibitors: 2. Structure-based optimization.

Yechun Xu, Lele Zhao, Z. Miao, 2015, Journal of medicinal chemistry.

Crystal Structures of Two Aminoglycoside Kinases Bound with a Eukaryotic Protein Kinase Inhibitor

D. Fong, A. Berghuis, B. Xiong, 2011, PloS one.

Tranylcypromine and 6-trifluoroethyl thienopyrimidine hybrid as LSD1 inhibitor.

Tongchao Liu, Yabing Chen, B. Xiong, 2019, Bioorganic & medicinal chemistry letters.

Structure-Based Discovery of a Series of NSD2-PWWP1 Inhibitors

Tongchao Liu, M. Geng, B. Xiong, 2022, Journal of Medicinal Chemistry.

2-Amino-nicotinamide induces apoptosis of prostate cancer cells via inhibition of PI3K/AKT and phosphorylation of STA3/JAK2

Changchun Zhou, Jia Wei, B. Xiong, 2020 .

Rational Design and Evaluation of 6-(Pyrimidin-2-ylamino)-3,4-dihydroquinoxalin-2(1H)-ones as Polypharmacological Inhibitors of BET and Kinases.

B. Xiong, D. Pei, D. Cao, 2020, Journal of medicinal chemistry.

Discovery of potent β-secretase (bace-1) inhibitors by the synthesis of isophthalamide-containing hybrids

B. Xiong, Xin Wang, Hai-Yan Zhang, 2009, Acta Pharmacologica Sinica.

NMR-based platform for fragment-based lead discovery used in screening BRD4-targeted compounds

Ye-chun Xu, Jun Yu, B. Xiong, 2016, Acta Pharmacologica Sinica.

Discovery of a novel DDRs kinase inhibitor XBLJ-13 for the treatment of idiopathic pulmonary fibrosis

Yi Zang, B. Xiong, Xuan Zhang, 2021, Acta Pharmacologica Sinica.

BSSF: a fingerprint based ultrafast binding site similarity search and function analysis server

Jie Wu, Hualiang Jiang, Bing Xiong, 2010, BMC Bioinformatics.

Design and optimization of purine derivatives as in vivo active PDE10A inhibitors.

Xuechu Zhen, Haibin Luo, Yu-Chih Liu, 2017, Bioorganic & medicinal chemistry.

Water PMF for predicting the properties of water molecules in protein binding site

Hualiang Jiang, Mingyue Zheng, Bing Xiong, 2013, J. Comput. Chem..

Design, Synthesis and Biological Evaluation of 6-(2,6-Dichloro-3,5-dimethoxyphenyl)-4-substituted-1H-indazoles as Potent Fibroblast Growth Factor Receptor Inhibitors

M. Geng, B. Xiong, Dongmei Zhao, 2016, Molecules.

Tetrahydroisoquinolines as novel histone deacetylase inhibitors for treatment of cancer

M. Geng, B. Xiong, Hongchun Liu, 2016, Acta pharmaceutica Sinica. B.

Discovery of a series of 1H-pyrrolo[2,3-b]pyridine compounds as potent TNIK inhibitors.

Tongchao Liu, Z. Miao, B. Xiong, 2020, Bioorganic & medicinal chemistry letters.

Structure of the Antibiotic Resistance Factor Spectinomycin Phosphotransferase from Legionella pneumophila*

D. Fong, A. Berghuis, B. Xiong, 2010, The Journal of Biological Chemistry.

Energetic factors determining the binding of type I inhibitors to c-Met kinase: experimental studies and quantum mechanical calculations

Bing Xiong, Xin Wang, Jing Ai, 2013, Acta Pharmacologica Sinica.